NCT07482306

Brief Summary

Telemedicine, the use of telecommunication technologies to provide healthcare services remotely, has grown exponentially in the last decade. The COVID-19 pandemic highlighted the potential of these approaches as routine clinical interactions transitioned from in-person to virtual modalities around the world. While some telemedicine applications are only feasible in high-resource settings, other types have been shown to be effective in low and middle-income countries (LMICs). Interventions that utilize mobile devices such as cellular phones and digital tablets, collectively known as mobile health or mHealth, may enable greater patient access to some services and reduce the strain on resource-limited health systems. Here we describe the use of an mHealth strategy to facilitate delivery of cervical cancer screening results in El Salvador.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,103

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

Same day

First QC Date

March 16, 2026

Last Update Submit

March 16, 2026

Conditions

Cervical Cancer Screening

Outcome Measures

Primary Outcomes (2)

  • Proportion of results received

    Proportion of women who received their results in each group

    45 days

  • Proportion of results received

    Proportion of women who received their results in each group within 45 days

    45 days

Study Arms (2)

Telemedicine

ACTIVE COMPARATOR

Received screening result through SMS message

Behavioral: Telemedicine

Control

NO INTERVENTION

Received screening result in person

Interventions

TelemedicineBEHAVIORAL

Women receive their screening results via SMS message instead of in person

Telemedicine

Eligibility Criteria

Age30 Years - 59 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiologically born females
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 30-59

You may not qualify if:

  • No history of cervical cancer
  • No HPV testing in the past 5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ministry of Health Clinics

San Salvador, 000000000, El Salvador

Location

MeSH Terms

Interventions

Telemedicine

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Miriam Cremer, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2026

First Posted

March 19, 2026

Study Start

January 31, 2024

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations

EL(1)